Nathaniel Simons
Meritage Group
Nathaniel Simons The Clorox Company stake
total: 301
Meritage Group CLX trades
- Total transactions:
- 6
- New positions:
- 2
- Sold out:
- 2
- Reduced:
- 2
- Held since:
- 2023 Q3
- Held for:
- 2 quarters
- Latest activity:
- 2024 Q1
According to 2026 Q2 report, Nathaniel Simons doesn't hold any The Clorox Company (CLX) shares. To date, the estimated cost basis is nearly $131.2 for "buy" trades and estimated average "sell" price is $142.34. Meritage Group first purchased CLX in 2022 Q1, initially acquiring 2,414 shares. Nathaniel Simons later completely sold out the position and invested in The Clorox Company again in 2023 Q3. Since the initial investment in The Clorox Company (CLX), Meritage Group has made 5 more transactions.
When did Nathaniel Simons sell The Clorox Company (CLX)?
Nathaniel Simons sold off the entire The Clorox Company (CLX) position in 2024 Q1.
When did Nathaniel Simons buy The Clorox Company (CLX)?
Nathaniel Simons first invested in The Clorox Company (CLX) in 2022 Q1 at the reported quarter-end price of $139.19 per share.
What's the cost basis of Meritage Group's CLX stake?
The estimated cost basis for The Clorox Company (CLX) stake is around $131.20 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $131.20
- Weighted AVG sell price:
- $142.34
Nathaniel Simons's historical trades in The Clorox Company
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q1
|
0.00%
|
0
|
$142.34
|
|
-100% (-1,932)
|
-0.01%
|
|
2023 Q4
|
0.01%
|
1,932
|
$142.34
|
$275,000
|
-16.62% (-385)
|
-0%
|
|
2023 Q3
|
0.01%
|
2,317
|
$131.20
|
$304,000
|
new
|
+0.01%
|
|
2022 Q3
|
0.00%
|
0
|
$140.99
|
|
-100% (-1,610)
|
-0.01%
|
|
2022 Q2
|
0.01%
|
1,610
|
$140.99
|
$227,000
|
-33.31% (-804)
|
-0%
|
|
2022 Q1
|
0.01%
|
2,414
|
$139.19
|
$336,000
|
new
|
+0.01%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.